Covalent Fluorescent Probes for Cancer Cell Detection
Covalent Fluorescent Probes for Cancer Cell Detection
批准号:
8065802
负责人:
NATHANAEL Schiander GRAY
金额:
$14.19万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-09-01 至 2013-08-31
关键词:
Affinity ChromatographyBODIPYBenzodiazepinesBiological MarkersBiotinBostonCancer BiologyCancer CenterCancer cell lineCell physiologyCellsChromosomal RearrangementCollaborationsCysteineDana-Farber Cancer InstituteDetectionDevelopmentEpidermal Growth Factor ReceptorEquilibriumEventFamilyFibroblast Growth Factor ReceptorsFluorescenceFluorescent ProbesGene AmplificationGenesGoalsGray unit of radiation doseImageryInstitutionLabelLibrariesMalignant NeoplasmsMass Spectrum AnalysisMentorsMethodsMicroscopyPersonsPhosphotransferasesPoint MutationPopulationProtein KinaseRelative (related person)Research PersonnelScreening procedureSiteStaining methodStainsTrainingYangabstractingbasebiological systemscancer cellcareercareer developmentcellular engineeringcovalent bondfluorescence imagingimaging probeinhibitor/antagonistkinase inhibitormedical schoolsmembernovelscaffoldsensorskillssmall moleculetool
中文摘要
摘要:荧光成像是一种强大的工具,可以可视化群体内特定的细胞状态;然而,现有的荧光标记方法在实验上对许多生物系统是不可行的。此外,相对于现有的荧光成像方法,荧光小分子细胞状态传感器可能提供一个有价值的替代方案,具有显著的优势。的总体目标
英文摘要
Abstract: Fluorescence imaging is a powerful tool that permits visualization of specific cell states within a population; however, existing methods for fluorescence labeling are not experimentally accessible for many biological systems. Furthermore, fluorescent small-molecule sensors of cell state may provide a valuable alternative with significant benefits relative to existing methods for fluorescence imaging. The overall goal of
this project is to create fluorescent small molecule ATP-site directed probes that can selectively label particular kinases and serve as imaging probes of normal versus pathological cell state. Protein kinases are in many ways ideal targets for the development of selective small molecule imaging probes for use in cancer biology.
This is because protein kinases are involved in most cellular processes and changes in their localization, accessibility, and abundance are associated with changes in cellular state. Protein kinases have been used as biomarkers in cancer biology because the loss of endogenous kinase regulatory mechanisms by point mutations, gene deletions, gene amplifications, and chromosomal rearrangements has been well-established
as crucial events in many cancers. The specific aims of this project are to: 1) Synthesize fluorescently-tagged kinase inhibitors capable of forming covalent bonds with ATP-site cysteine residues; 2) Use microscopy-based screening ofthe compounds prepared in Aim 1 to identify compounds that are selective-probes of normal and pathological cellular states and 3) Identify the intracellular target(s) of active compounds identified in Aim 2.
This proposed is the extension of an ongoing collaboration between Drs. Nathanael Gray (Dana Farber Cancer Institute), Priscilla Yang (Harvard Medical School) and Wei Zhang (UMass Boston). All three are also members of the Dana Farber/Harvard Cancer Center. One of the strong points of this proposal is that each Co-Pl is responsible for one of the three Specific Aims allowing the project to be benefited by the balanced skills and expertise that each person and their subsequent institution brings to the partnership. Because all three investigators are eariy in their careers, Drs. Gray, Yang and Zhang will benefit from career development activities and mentors who are intemal and extemal. Additionally, the Training Core will significantiy contribute to this project.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Targeting CDK7 in CCNE1-amplified Ovarian Cancer
-
批准号:10367792
-
项目类别:
-
资助金额:$72.71万
-
财政年份:2022
-
负责人:NATHANAEL Schiander GRAY
-
依托单位:
Targeting CDK7 in CCNE1-amplified Ovarian Cancer
-
批准号:10576332
-
项目类别:
-
资助金额:$68.47万
-
财政年份:2022
-
负责人:NATHANAEL Schiander GRAY
-
依托单位:
Small molecule-induced degradation of dengue proteins as an antiviral strategy
-
批准号:10472071
-
项目类别:
-
资助金额:$81.09万
-
财政年份:2020
-
负责人:NATHANAEL Schiander GRAY
-
依托单位:
Small molecule-induced degradation of dengue proteins as an antiviral strategy
-
批准号:10052821
-
项目类别:
-
资助金额:$82.98万
-
财政年份:2020
-
负责人:NATHANAEL Schiander GRAY
-
依托单位:
Validating the Flavivirus Envelope Protein as an Antiviral Target
-
批准号:10338189
-
项目类别:
-
资助金额:$96.12万
-
财政年份:2020
-
负责人:NATHANAEL Schiander GRAY
-
依托单位:
Validating the Flavivirus Envelope Protein as an Antiviral Target
-
批准号:10578759
-
项目类别:
-
资助金额:$96.12万
-
财政年份:2020
-
负责人:NATHANAEL Schiander GRAY
-
依托单位:
Validating the Flavivirus Envelope Protein as an Antiviral Target
-
批准号:10413666
-
项目类别:
-
资助金额:$85.19万
-
财政年份:2020
-
负责人:NATHANAEL Schiander GRAY
-
依托单位:
Small molecule-induced degradation of dengue proteins as an antiviral strategy
-
批准号:10661608
-
项目类别:
-
资助金额:$83.59万
-
财政年份:2020
-
负责人:NATHANAEL Schiander GRAY
-
依托单位:
Small molecule-induced degradation of dengue proteins as an antiviral strategy
-
批准号:10429876
-
项目类别:
-
资助金额:$81.11万
-
财政年份:2020
-
负责人:NATHANAEL Schiander GRAY
-
依托单位:
Targeting the transcriptional and epigenetic landscape in chemo-refractory Small-Cell Lung Cancer
-
批准号:10174856
-
项目类别:
-
资助金额:$65.64万
-
财政年份:2017
-
负责人:NATHANAEL Schiander GRAY
-
依托单位:
Development of covalent PIP4K2 inhibitors for the treatment of p53 deficient lung tumors
-
批准号:8942703
-
项目类别:
-
资助金额:$54.09万
-
财政年份:2015
-
负责人:NATHANAEL Schiander GRAY
-
依托单位:
Development of covalent PIP4K2 inhibitors for the treatment of p53 deficient lung tumors
-
批准号:9262888
-
项目类别:
-
资助金额:$54.09万
-
财政年份:2015
-
负责人:NATHANAEL Schiander GRAY
-
依托单位:
Development and Application of Selective Covalent Cdk7 Inhibitors
-
批准号:8701553
-
项目类别:
-
资助金额:$50.6万
-
财政年份:2014
-
负责人:NATHANAEL Schiander GRAY
-
依托单位:
Development and Application of Selective Covalent Cdk7 Inhibitors
-
批准号:9033083
-
项目类别:
-
资助金额:$50.12万
-
财政年份:2014
-
负责人:NATHANAEL Schiander GRAY
-
依托单位:
Development and Application of Selective Covalent Cdk7 Inhibitors
-
批准号:8827302
-
项目类别:
-
资助金额:$50.36万
-
财政年份:2014
-
负责人:NATHANAEL Schiander GRAY
-
依托单位:
MALT1 inhibitors for the treatment of chemo-resistant ABC-DLBCL
-
批准号:8924770
-
项目类别:
-
资助金额:$70.8万
-
财政年份:2013
-
负责人:NATHANAEL Schiander GRAY
-
依托单位:
MALT1 inhibitors for the treatment of chemo-resistant ABC-DLBCL
-
批准号:9330826
-
项目类别:
-
资助金额:$69.94万
-
财政年份:2013
-
负责人:NATHANAEL Schiander GRAY
-
依托单位:
Developing Selective EphA2 Inhibitors for the treatment of Cancer
-
批准号:8429912
-
项目类别:
-
资助金额:$52.45万
-
财政年份:2013
-
负责人:NATHANAEL Schiander GRAY
-
依托单位:
Developing Selective EphA2 Inhibitors for the treatment of Cancer
-
批准号:8643194
-
项目类别:
-
资助金额:$50.88万
-
财政年份:2013
-
负责人:NATHANAEL Schiander GRAY
-
依托单位:
Chemical Tools for the Study of Dengue Virus Entry
-
批准号:8653822
-
项目类别:
-
资助金额:$42.16万
-
财政年份:2013
-
负责人:NATHANAEL Schiander GRAY
-
依托单位:
国内基金
海外基金
登录
查看更多内容
新型光动力BODIPY衍生物靶向FDX1诱导铜死亡抑制骨肉瘤的机制研究
-
批准号:2026JJ50597
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:李劲松
-
依托单位:
基于分子内动态调控的BODIPY自闪染料设计及其活细胞多色超分辨成像研究
-
批准号:22508006
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.00万元
-
批准年份:2025
-
负责人:吴清华
-
依托单位:
稠环连接的扩展卟啉BODIPY的合成及光物理性能研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
meso位苯基取代BODIPY染料的自组装行为调控与光敏功能强化
-
批准号:22508103
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.00万元
-
批准年份:2025
-
负责人:牛慧玉
-
依托单位:
基于BODIPY中心核的短波红外小分子受体材料
-
批准号:52503255
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.00万元
-
批准年份:2025
-
负责人:苗俊辉
-
依托单位:
基于氮宾/卡宾化学的光控分子内环化策略构建BODIPY光转换染料用于低光毒性活细胞超分辨成像
-
批准号:22578006
-
项目类别:面上项目
-
资助金额:50.00万元
-
批准年份:2025
-
负责人:郝二红
-
依托单位:
平面手性硼酸催化剂的构筑及其在硼手性BODIPY材料分子合成中的应用
-
批准号:22502048
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.00万元
-
批准年份:2025
-
负责人:宋键
-
依托单位:
Meso位C=N修饰的BODIPY类AIE光敏剂构筑及Aβ成像和光氧化治疗一体化研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:15.0万元
-
批准年份:2024
-
负责人:史文静
-
依托单位:
氟硼二吡咯(BODIPY)光敏剂分子近红外吸收和高效三重态协同调控的光物理机理研究
-
批准号:12474257
-
项目类别:面上项目
-
资助金额:52.00万元
-
批准年份:2024
-
负责人:杨勇刚
-
依托单位:
基于光控分子内开环/闭环策略的BODIPY类可逆光转换染料构建及其超分辨率成像应用研究
-
批准号:22478005
-
项目类别:面上项目
-
资助金额:50.00万元
-
批准年份:2024
-
负责人:焦莉娟
-
依托单位: